A Phase 2, Fast Real-time Assessment of Combination Therapies in Immuno-ONcology Study in Participants With Advanced Gastric Cancer (FRACTION-Gastric Cancer)

What is the purpose of this trial?

The purpose of this study is to determine whether Nivolumab in combination with other therapies is more effective than Nivolumab in combination with Ipilimumab in treating patients/subjects with advanced gastric cancer.

Bristol-Myers Squibb Company

Dates: 10/09/2017 - 11/30/2021

Last Updated: 03/07/2018

Study HIC#: 2000020656

Get Involved

For more information about this study, contact:
Kamil Sadowski
+1 203-785-6666

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image